ASTRAZENECA VACCINE: the risk of THROMBOSIS is much higher for those who get sick from COVID. A STUDIO says so
The THROMBOSIS risk is much higher for those who get sick from COVIDThe results of a research, published by British Medical Journal, conducted on 280,000 Danish and Norwegian adults vaccinated (with the first dose AstraZeneca) between February and March, confirms the low possibility for the development of THROMBOSIS to those who have contracted the CORONAVIRUS in moderate or severe form. Very low, or almost null instead, i dangers that run with the inoculation of the vaccine for those who have not contracted COVID-19.
As can be read from the research also reported by Republic, the risk of rare blood clotting following CORONAVIRUS infections is 100 times greater than normaland, and much higher than the post-vaccine risks. The study would therefore suggest that vaccines, protecting against infection, they also offer protection against possible thrombosis that can result from it. The researchers counted the number of thrombosis cases diagnosed within two weeks of Covid-19 infection and, in parallel, after the first dose of the vaccine.
It thus emerged that the Cerebral vein thromboses are more common in those who have contracted Covid-19. Additionally, 30% of thromboembolic events occurred in people under the age of 30. Compared to the observations on thrombosis cases after the vaccine, the risk is 8-10 times higher, while it is 100 times higher than the normal average. These are the conclusions of the authors of the research. Professor Paul Harrison said: “There are concerns about the possible associations between vaccines and thrombosis, leading governments and regulators to restrict the use of certain vaccines. However, we must have faith, it is the only weapon “.